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Incidence of Hidradenitis Suppurativa and Associated
Factors: A Population-Based Study of Olmsted
County, Minnesota
Benjamin G. Vazquez1,3, Ali Alikhan1,3, Amy L. Weaver2, David A. Wetter1 and Mark D. Davis1
There are no population-based incidence studies of hidradenitis suppurativa (HS). Using the medical record
linkage system of the Rochester Epidemiology Project, we sought to determine the incidence of the disease, as
well as other associations and characteristics, among HS patients diagnosed in Olmsted County, Minnesota,
between 1968 and 2008. Incidence was estimated using the decennial census data for the county. Logistic
regression models were fit to evaluate associations between patient characteristics and disease severity. A total
of 268 incident cases were identified, with an overall annual age- and sex-adjusted incidence of 6.0 per 100,000.
Age-adjusted incidence was significantly higher in women compared with men (8.2 (95% confidence interval
(CI), 7.0–9.3) vs. 3.8 (95% CI, 3.0–4.7). The highest incidence was among young women aged 20–29 years (18.4 per
100,000). The incidence has risen over the past four decades, particularly among women. Women were more
likely to have axillary and upper anterior torso involvement, whereas men were more likely to have perineal or
perianal disease. In addition, 54.9% (140/255) patients were obese; 70.2% were current or former smokers; 42.9%
carried a diagnosis of depression; 36.2% carried a diagnosis of acne; and 6% had pilonidal disease. Smoking and
gender were significantly associated with more severe disease.
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INTRODUCTION
Hidradenitis suppurativa (HS) is a chronic, recurrent,
inflammatory disorder of hair follicles in apocrine gland–-
bearing sites, resulting in abscesses and potentially fistula
formation (Alikhan et al., 2009). Associations with smoking,
obesity, and inflammatory bowel disease have been de-
scribed (Revuz et al., 2008; Sartorius et al., 2009; van der Zee
et al., 2010). HS can be debilitating and devastating,
significantly compromising the quality of life (Wolkenstein
et al., 2007; Matusiak et al., 2010a; Esmann and Jemec,
2011). Furthermore, it represents a diagnostic and treatment
challenge not only to dermatologists but also to primary care
physicians and surgeons (Alikhan et al., 2009).
Despite the severity of the disorder, little epidemiological
data have been published (Alikhan et al., 2009). Depending
on the study, prevalence rates have ranged from 0.00033 to
4% (Fitzsimmons et al., 1985; Jemec, 1988; Lookingbill,
1988; Jemec et al., 1996; Revuz et al., 2008). To our
knowledge, there are no population-based data on incidence.
The primary purpose of this study was to calculate the
incidence of HS using population-based data from a single
well-studied and well-characterized US county. Data relating
to demographic variables, diagnostic criteria, treatment and
outcomes, and associations with other medical disorders are
also presented.
RESULTS
Between 1968 and 2008, 1,263 patients who had received a
diagnosis of HS were identified using the Rochester
Epidemiology Project (REP) resources. Of these, 268 were
confirmed to have a first-ever diagnosis of HS as a resident of
Olmsted County using the criteria outlined below.
The characteristics of the 268 patients confirmed to have
HS are summarized in Table 1. The median age at the time of
diagnosis was 30.6 years (range 9.9–78.5 years). The median
time between onset of symptoms and diagnosis was 3.3 years
(range 0–30 years). The majority of patients were white
(90.3%), reflecting the general demographics of Olmsted
County. The median body mass index (BMI) was 31.1 kgm2,
and 54.9% (140/255) had a BMI of 30 kgm2 or greater. At
the time of their diagnosis, 57.7% of cases reported currently
smoking and an additional 12.5% had smoked before their
diagnosis.
Incidence data are summarized in Tables 2 and 3. The
overall annual age- and sex-adjusted incidence of HS in
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Olmsted County during 1968–2008 was 6.0 per 100,000
person-years (95% confidence interval (CI), 5.2–6.7). The
incidence was significantly higher among women than
among men, 8.2 per 100,000 (95% CI, 7.0–9.3) and 3.8 per
100,000 (95% CI, 3.0–4.7), respectively (Po0.001). The
highest incidence was among women aged 20–29 years
(18.4 per 100,000). This was also the age range with the
highest incidence for men (7.4 per 100,000). There
was a sharp decline in incidence among women after the
age of 49 years. There was also a decline among men, but
the rate of decline across the age groups after the age of 20
years was significantly different between the sexes
(P¼0.014). Incidence of HS by calendar decade demon-
strates a steady increase from 4.3 per 100,000 (95%
CI, 2.8–5.8) during 1970–1979 to 9.6 per 100,000 (95% CI,
7.8–11.3) during 2000–2008. This increasing trend across the
decades was more apparent in women (Po0.001) than in
men (P¼0.20).
At the time of diagnosis, 160 (59.7%) patients had Hurley
stage I disease, 102 (38.1%) had Hurley stage II disease, and
6 (2.2%) had Hurley stage III disease. Disease involvement by
site and gender is summarized in Table 4. Axillary involve-
ment was present in 165 (61.6%) patients, and was
significantly more common in women than in men (67.7%
vs. 46.8%, P¼ 0.001), as were upper torso involvement
(24.9% vs. 2.5%, Po0.001) and groin or thigh involvement
(73.0% vs. 60.8%, P¼ 0.047). Conversely, men were
significantly more likely to have perianal or perineal disease
(20.3% vs. 5.8%, Po0.001).
A diagnosis of depression was found in 115 (42.9%)
patients. A history of acne was present in 97 (36.2%) of the
patients. On the basis of clinical description, 28 (28.9%) had
mild acne, 39 (40.2%) had moderate acne, and 24 (24.7%)
had severe acne. Pilonidal disease was present in 16 (6%)
patients, but none carried a diagnosis of acne conglobata or
dissecting cellulitis of the scalp. Aside from acne and
pilonidal disease, no other concurrent dermatological dis-
order or malignancy occurred frequently enough to warrant
analysis. The same is true of internal malignancies.
Table 1. Demographic and diagnostic characteristics
of hs patients
Characteristic Total (N=268)
Gender
Female 189 (70.5%)
Male 79 (29.5%)
Age at diagnosis (years)
Mean (SD) 32.9 (12.6)
Median 30.6
Range (9.9–78.5)
Race
White 241 (90.3%)
Non-white 26 (9.7%)
Unknown 1
Education level (years)
412 139 (57.9%)
12 57 (23.8%)
o12 44 (18.3%)
Unknown 28
BMI (kgm2)
N 249
Mean (SD) 32.6 (8.7)
Median 31.1
Range (18.3–66.7)
BMI breakdown
Underweight or normal (o25) 49 (19.2%)
Overweight (25.0–29.9) 66 (25.9%)
WHO class I obesity (30.0–34.9) 49 (19.2%)
WHO class II obesity (35.0–39.9) 49 (19.2%)
WHO class III obesity (40.0–49.9) 33 (12.9%)
Super obese (50+) 9 (3.5%)
Unknown1 13
Smoking status
Never 79 (29.8%)
Current 153 (57.7%)
Former 33 (12.5%)
Unknown 3
1st or 2nd degree family members affected?
Yes 22 (8.2%)
No 117 (43.7%)
Unknown 129 (48.1%)
Table 1. Continued
Characteristic Total (N=268)
Time between symptom onset and diagnosis (years)
N 156
Mean (SD) 5.1 (5.8)
Median 3.3
Range (0.0–30.0)
Diagnosis of HS rendered by
Dermatologist 171 (63.8%)
Non-dermatologist but meets 4 criteria listed 97 (36.2%)
Abbreviations: BMI, body mass index; HS, hidradenitis suppurativa;
WHO, World Health Organization.
1Of the 19 patients missing BMI, 6 patients had a description of body
habitus by the physician that was recorded and abstracted.
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Patient characteristics were evaluated for an association
with disease severity, defined as Hurley grade I vs. II or III
(Table 5). In univariate analysis, age, male sex, and any
history of smoking demonstrated a statistically significant
association with greater disease severity. However, after
adjusting for age, only male sex remained significantly
associated with disease severity (P¼ 0.015). There were no
significant associations identified between disease severity
and BMI, depression, acne, or pilonidal disease.
DISCUSSION
Our population-based study of HS demonstrates an overall
annual incidence of 6.0 per 100,000 person-years during
1968–2008. The highest incidence is among young women
aged 20–29 years (18.4 per 100,000). The incidence is
significantly higher among women than among men, and the
incidence among women has trended upward over the past
four decades. The incidence is highest between the ages of 20
and 49 years, with a particularly steep decline among
women, after the age of 49 years. Male patients and patients
with a smoking history were more likely to have a higher
disease severity. In terms of site involvement, women were
more likely to have axillary and upper anterior torso
involvement, whereas men were more likely to have perineal
or perianal disease. The majority of patients were overweight
or obese, and many carried a diagnosis of depression.
Prevalence of HS has varied from as low as 1 in 3,000 to as
high as 4% (Lookingbill, 1988; Jemec et al., 1996). Two fairly
recent studies have estimated the prevalence to be about 1%
(Jemec et al., 1996; Revuz et al., 2008), and as high as 4%
among young adults at a Danish sexually transmitted disease
clinic (Jemec et al., 1996). Thus, it has been suggested that
HS may be a common disease. However, these studies may
have been influenced by referral bias and issues with patient
self-reporting. In contrast, our data suggest that HS is a rare
disease. Interestingly, the majority of cases we reviewed did
not meet the diagnostic criteria proposed by Alikhan et al.
(2009).
It is noteworthy that the incidence of HS appears to be
increasing steadily over the past four decades. This trend was
noted particularly among women. Although it is beyond the
Table 2. Incidence of hidradenitis suppurativa per
100,000 persons by age and gender in Olmsted
county, Minnesota, 1968–2008
Women Men Both sexes
Age group,
years
No. of
cases
Rate per
100,000
No. of
cases
Rate per
100,000
No. of
cases
Rate per
100,000
0–19 30 4.4 7 1.0 37 2.7
20–29 66 18.4 23 7.4 89 13.3
30–39 50 14.2 23 6.7 73 10.5
40–49 36 12.3 14 5.0 50 8.7
50–59 3 1.5 5 2.6 8 2.0
60+ 4 1.2 7 2.9 11 1.9
Total (95%
CI)
8.2
(7.0–9.3)1
3.8
(3.0–4.7)1
6.0
(5.2–6.7)2
Abbreviation: CI, confidence interval.
1Incidence per 100,000 person-years is directly age-adjusted to the
population structure of the US total population in 2000.
2Incidence per 100,000 person-years is directly age- and sex-adjusted to
the population structure of the US total population in 2000.
Table 3. Incidence of hidradenitis suppurativa per 100,000 persons by 10-year intervals in Olmsted County,
Minnesota, 1970–2008
Women Men Both sexes
Period1 No. of cases
Incidence rate per
100,000 (95% CI)2 No. of cases
Incidence rate per
100,000 (95% CI)2 No. of cases
Incidence rate per
100,000 (95% CI)3
1970–1979 22 5.4 (3.0–7.7) 13 3.2 (1.4–5.0) 35 4.3 (2.8–5.8)
1980–1989 28 5.3 (3.3–7.4) 18 4.0 (2.1–5.8) 46 4.6 (3.2–6.0)
1990–1999 52 8.7 (6.3–11.0) 16 2.8 (1.4–4.2) 68 5.7 (4.4–7.1)
2000–2008 85 14.1 (11.1–17.1) 30 5.2 (3.3–7.1) 115 9.6 (7.8–11.3)
Abbreviation: CI, confidence interval.
1Four cases (two women and two men) were omitted from 1968–1969.
2Incidence per 100,000 person-years is directly age-adjusted to the population structure of the US total population in 2000.
3Incidence per 100,000 person-years is directly age- and sex-adjusted to the population structure of the US total population in 2000.
Table 4. Site of disease by gender
Location
Female
(N=189)
Male
(N=79) P-value1
Abdomen 5 (2.7%) 5 (6.3%) 0.15
Chest, breast, or inframammary 47 (24.9%) 2 (2.5%) o0.001
Axilla 128 (67.7%) 37 (46.8%) 0.001
Perineal or perianal 11 (5.8%) 16 (20.3%) o0.001
Scrotum NA 5 (6.3%) NA
Groin or thigh 138 (73.0%) 48 (60.8%) 0.047
Buttock or gluteal cleft 27 (14.3%) 10 (12.7%) 0.72
Neck or ear 3 (1.6%) 3 (3.8%) 0.27
Abbreviation: NA, not applicable.
1Two-sided chi-square test.
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scope of this study to identify the underlying etiology for this
trend, it is likely multifactorial. Obesity, smoking, and
physicians’ awareness and capacity to diagnose this disease
may all have a role.
Peak incidence of HS occurred in the third decade, with
sharp decline after the fifth decade. Revuz et al. (2008)
demonstrated a similar decrease of HS prevalence among
people aged 55 years and older. This trend is likely due to the
onset of menopause among women, where the sharpest
decline was noted. The onset of HS among women after
menopause has previously been reported as rare (Thornton
and Abcarian, 1978; Fitzsimmons et al., 1985), a claim
supported by our data.
Our data demonstrate several important differences in
disease characteristics between men and women. Axillary,
upper anterior torso, and groin involvement were more
common among women, whereas perianal and perineal
involvement were more common among men. Similar
patterns have been noted in previously studied HS patient
populations (Anderson and Dockerty, 1958; Jemec, 1988;
Jemec et al., 1996; Canoui-Poitrine et al., 2009). In addition,
men were more likely than women to have Hurley stage II or
III disease. Increased disease severity among male HS
patients has been demonstrated previously by Canoui-
Poitrine et al. (2009) using the Sartorius scoring system.
Nearly 70% of patients in our study were current or former
smokers, which is similar to or lower than the data published
by Konig et al. (1999), Revuz et al. (2008), Canoui-Poitrine
et al. (2009), and Sartorius et al. (2009). It is well accepted
that smoking may be a triggering or exacerbating factor in HS.
In addition, we found smoking to be associated with worse
disease (higher Hurley stage), which was also demonstrated
by Sartorius et al. (2009), but not by Canoui-Poitrine et al.
(2009). There is even some evidence that smoking cessation
may improve HS (Simonart, 2010).
On average, patients in our study were obese (mean
BMI¼32.6). This is consistent with, although somewhat
higher than, the data reported by Sartorius et al. (2009) (mean
BMI¼28.3, overweight) and much higher than the data
reported by Canoui-Poitrine et al. (2009) (mean BMI¼25.6,
overweight) and Revuz et al. (2008) (mean BMI¼25.6,
overweight). We did not find a correlation between BMI and
more severe disease, although this has been demonstrated
previously by Canoui-Poitrine et al. (2009).
Although HS is commonly grouped in a follicular
occlusion tetrad with pilonidal disease, acne conglobata,
and dissecting cellulitis, we only appreciated an association
with pilonidal disease (6% of patients). This association is
somewhat weaker than that demonstrated by Canoui-Poitrine
et al. (2009), in which 90 of 302 (30.2%) HS patients had
concomitant pilonidal disease. Nearly 40% of patients
carried a current or prior diagnosis of acne vulgaris. It is
difficult to comment on the accuracy of these data, as
oftentimes patients do not seek medical care for acne, and
thus acne is not mentioned in notes or coded for billing
purposes. In any case, we did not find a correlation between
acne severity and HS severity, and a diagnosis of acne was
seen in a similar percentage of male and female patients
(35.9% and 36.7%, respectively).
Over 40% of HS patients in our study carried a diagnosis
of depression, compared with a lifetime prevalence of mood
disorders in the general population of 20.8% (Kessler et al.,
2005). This is not surprising, as several studies have
demonstrated a decreased quality of life in patients with HS
(Wolkenstein et al., 2007; Matusiak et al., 2010a, b). In fact,
Table 5. Univariate and multivariate analysis of
gender, smoking, BMI, acne, and depression as it
relates to HS severity
Characteristic
Hurley grade II
or III, no. (%) OR (95% CI)
P-value from
univariate
logistic regression
analysis
Age at diagnosis
(years)1
0.021
p23.4 (N=67) 20 (29.9%) Referent
23.5–30.6 (N=68) 34 (50.0%) 2.4 (1.2–4.8)
30.7–40.3 (N=66) 21 (31.8%) 1.1 (0.5–2.3)
X40.5 (N=67) 33 (49.3%) 2.3 (1.1–4.6)
Gender 0.006
Male (N=79) 42 (53.2%) 2.1 (1.2–3.6)
Female (N=189) 66 (34.9%) Referent
Smoking history 0.016
Past/current (N=186) 84 (45.2%) 2.0 (1.1–3.5)
Never (N=79) 23 (29.1%) Referent
Unknown (N=3)
BMI 0.63
X30 kgm2 (N=140) 59 (42.1%) 1.1 (0.7–1.9)
o30 kgm2 (N=115) 453 (39.1%) Referent
Unknown (N=13)
Acne diagnosis ever 0.35
Yes (N=97) 43 (44.3%) 1.3 (0.8–2.1)
No (N=169) 65 (38.5%) Referent
Unknown (N=2)
Depression diagnosis
ever
0.74
Yes (N=115) 45 (39.1%) 0.9 (0.6–1.5)
No (N=153) 63 (41.2%) Referent
Pilonidal disease 0.77
Yes (N=16) 7 (43.8%) 1.2 (0.4–3.2)
No (N=252) 101 (40.1%) Referent
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds
ratio.
1Age was categorized based on the quartiles of the age distribution.
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patients with HS may have a lower quality of life than
patients with neurofibromatosis 1, chronic urticaria, psoriasis,
acne vulgaris, Darier disease, Hailey–Hailey disease, and
atopic dermatitis (Wolkenstein et al., 2007; Matusiak et al.,
2010a). Quality of life in HS has also been shown to correlate
with disease severity, duration, pain, continuous evolution,
particular locations (e.g., perianal), uncovered locations, and
more involved locations (Wolkenstein et al., 2007; Matusiak
et al., 2010a, b).
Our data have several important limitations. The popula-
tion studied was primarily Caucasian and limited to Southeast
Minnesota. Thus, data collected in our study may not be
representative of HS patients in other countries or even in
different parts of the US. Furthermore, strict diagnostic criteria
(described below) were used, which determined inclusion
into our study—it is possible that true cases of HS were
excluded. As one of the criteria was ‘‘symptomatology for at
least 6 months,’’ it is possible that early mild cases were
missed. Nevertheless, the overwhelming majority of excluded
cases were clearly not HS, but rather ruptured epidermoid
cysts, furuncles, folliculitis, or contact or irritant dermatitis; we
also noted that many cases were called HS simply because
symptoms occurred in common anatomic locations for HS
(e.g., axilla or groin). It is unlikely that many true cases of HS
were missed owing to our strict diagnostic criteria.
Although our study has several limitations, it is, to our
knowledge, a previously unreported population-based in-
cidence study on HS. We have demonstrated that HS is a rare
disease, although its incidence appears to be rising with time.
It is associated with a current or previous smoking history,
obesity, and gender. Furthermore, there is an association
between severity of HS and gender, as well as severity of HS
and smoking. There are also important differences in sites of
involvement between men and women. HS patients appear
to have high rates of depression. Further studies should be
prospectively conducted to more accurately assess the
clinical outcomes and optimal treatments of patients with HS.
MATERIALS AND METHODS
Study setting
We reviewed cases of HS within the population of Olmsted County,
Minnesota. Olmsted County is located in the southeastern corner of
Minnesota, roughly 90 miles southeast of Minneapolis and St Paul.
According to the 2010 US Census, Olmsted County had a population
of 144,000 people with over 70% of the population residing within
Rochester. The US Census data indicate that residents are largely
white—not of Hispanic origin (83% in 2010)—and the level of college
graduates is relatively higher than the general population of Minnesota
(39% report having a bachelor’s degree or higher in Olmsted county
compared with 31% for the entire state). Despite these educational
differences, prior comparisons have shown this population to be
socioeconomically and demographically similar to the general US
white population (Melton, 1996; Maradit Kremers et al., 2004).
This study was approved by the Mayo Clinic and Olmsted
Medical Center institutional review boards. Inpatient and outpatient
medical records were obtained for review using the REP. REP
is a unique Olmsted County centralized, computerized medical
records linkage system containing medical diagnoses and surgical
procedures for nearly all patients in Olmsted County since the 1960s
(Melton, 1996). This resource has been successful for various reasons,
including the following: (1) the county is isolated from other urban
centers, with virtually all medical care in the county concentrated
among a small number of providers (e.g., Mayo Clinic, Olmsted
Medical Group, Olmsted Community Hospital, regional hospitals,
private practitioners, and nursing homes); (2) the out-migration rates
are low, and there has been a net in-migration to the county; (3)
nearly all providers in the county use a unit medical record system in
which all medical information on each patient is accumulated within
a single dossier; and (4) detailed indices that contain all clinical and
pathologic diagnoses and surgical procedures that have been
recorded since 1966 have been carefully organized for research
purposes (Maradit Kremers et al., 2004). The overall result is that all
medical data (including death certificates) collected on an individual
by health-care providers at all levels of medical care are located in a
single file (Maradit Kremers et al., 2004).
Study criteria
Through the REP, all medical records for patients receiving a first-ever
diagnosis of HS from 1 January 1968 to 31 December 2008 were
identified and retrieved using various HICDA (Hospital Adaptation of
the International Classification of Diseases) codes (‘‘hydradenitis,
NOS,’’ ‘‘hidradenitis, suppurative,’’ ‘‘hydradenitis, suppurative,’’
‘‘hidradenitis, NOS, ‘‘hydradenitis, NOS,’’ and ‘‘infection, sweat
gland’’), Berkson codes (‘‘hydrosadenitis,’’ ‘‘inflammation, sweat
gland,’’ ‘‘hydradenitis, hydro-adenitis, hidrosadenitis,’’ and ‘‘hidrade-
nitis, hidro-adenitis, hidrosadenitis’’), and the International Classifica-
tion of Disease-9 code ‘‘hidradenitis.’’ Patients who did not provide
authorization for research purposes were excluded. Each chart was
reviewed to confirm a diagnosis of HS. This was done using the
criteria and algorithm outlined by Alikhan et al. (2009). Patients with
multiple, recurrent, chronic, and bilateral lesions primarily along the
milk line, but also in atypical locations (e.g., perineal and perianal
region), were considered to have a clinical diagnosis of HS (Table 6).
For our purposes, we considered chronic disease to be greater than 6
months duration (from the onset of symptoms). The date of diagnosis
used for our study was the date the patient received a first-ever
diagnosis of HS by either a dermatologist or a non-dermatologist
physician, provided that they met the clinical criteria outlined above.
Any chart in which the diagnosis was unclear was reviewed by both
abstractors (BGV and AA) to determine whether the clinical findings
and history met the outlined criteria. Patients not meeting these
criteria, and those for whom a consensus could not be made, were
excluded. The study was limited to incident cases; therefore, patients
with a diagnosis of HS before residing in Olmsted County were also
excluded.
Data collection
The medical records were reviewed by one of two abstractors and
the following information was abstracted. Socio-demographic data
include age at diagnosis, gender, race, and education level. In
addition, smoking status and family history of HS were collected.
BMI was calculated using any weight recorded within 6 months of
the diagnosis date; otherwise, the description of body habitus by the
physician was recorded if available. Comorbid diagnoses were
recorded, including depression, anxiety, history of internal malig-
nancy, history of cutaneous malignancy, history of acne, and other
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concurrent dermatological disorders. These were recorded as ever
having a diagnosis of these conditions. Patients with a history of
acne were graded as mild, moderate, or severe based on the
clinical description at the time of diagnosis (CDER, 2005). Anatomic
zones affected by HS were recorded, along with disease severity
using the Hurley staging system (Table 6) (Alikhan et al., 2009).The
abstracted data were entered into a database created for this
particular study using REDCap (Research Electronic Data Capture)
tools hosted at the Mayo Clinic (Harris et al., 2009). REDCap is a
secure, web-based application designed to support data capture for
research studies.
Statistical analyses
The data were analyzed using the SAS version 9.2. software package
(SAS Institute, Cary, NC). Age- and sex-specific incidence rates in
Olmsted County during 1968–2008 were calculated overall and by
calendar decade. The incidence rates were calculated with the
assumption that the entire population of Olmsted County was at risk.
The numerator was the number of persons with HS diagnosis within
this period and the denominator was obtained from the decennial
census data for 1968–2008, with linear interpolation between census
years. Rates were age and sex adjusted to the total population
structure of the US in 2000. The 95% CIs for the rates were
calculated assuming a Poisson error distribution.
The relation of incidence rates to sex, age, and time period of
diagnosis (1970–1979, 1980–1989, 1990–1999, 2000–2008) were
assessed by fitting generalized linear models assuming a Poisson
error structure using the SAS procedure GENMOD. The observations
used for the regression analysis were the crude incidence counts for
all combinations of sex, 10-year age groupings, and 10-year time
periods, which were offset by the natural logarithm of the number of
persons. In the modeling, we first fit sex and age group, testing for an
interaction between them, and then the interaction between sex and
time period. The significance values of linear trends across age
groupings and time periods were each assessed with likelihood ratio
statistics with 1 degree of freedom. Overdispersion was accounted
for by estimating a dispersion parameter (i.e., deviance divided by its
degrees of freedom), which was then used to adjust the variance of
the parameter estimates (McCullagh and Nelder, 1983).
The w2-test was used to compare the involvement at various
locations between male and female patients. Logistic regression
models were fit to evaluate the association between patient
characteristics and disease severity, defined as Hurley grade I vs. II
or III. Associations were summarized using the estimated odds
ratioOR and corresponding 95% CI. Each characteristic was
evaluated in a model with and without adjusting for age at HS
diagnosis. All calculated P-values were two-sided and P-values
o0.05 were considered statistically significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by the Center for Translational Science Activities
grant UL1 RR024150 and by the Rochester Epidemiology Project grant R01
AG034676 from the National Institute on Aging.
REFERENCES
Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a
comprehensive review. J Am Acad Dermatol 60:539–61
Anderson Jr MJ, Dockerty MB (1958) Perianal hidradenitis suppurativa; a
clinical and pathologic study. Dis Colon Rectum 1:23–31
Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F
et al. (2009) Clinical characteristics of a series of 302 French patients
with hidradenitis suppurativa, with an analysis of factors associated with
disease severity. J Am Acad Dermatol 61:51–7
CDER (2005) Guidance for Industry - Acne Vulgaris: Developing Drugs for
Treatment,. FDA edn. US Department of Health and Human Services:
Rockville, MD, 1–17
Esmann S, Jemec GB (2011) Psychosocial impact of hidradenitis suppurativa:
a qualitative study. Acta Dermatol Venereol 91:328–32
Fitzsimmons JS, Guilbert PR, Fitzsimmons EM (1985) Evidence of genetic
factors in hidradenitis suppurativa. Br J Dermatol 113:1–8
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009)
Research electronic data capture (REDCap)—a metadata-driven metho-
dology and workflow process for providing translational research
informatics support. J Biomed Informatics 42:377–81
Jemec GB (1988) The symptomatology of hidradenitis suppurativa in women.
Br J Dermatol 119:345–50
Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis
suppurativa and its potential precursor lesions. J Am Acad Dermatol
35:191–4
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005)
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders
in the National Comorbidity Survey Replication. Arch Gen Psychiatry
62:593–602
Konig A, Lehmann C, Rompel R, Happle R (1999) Cigarette smoking as a
triggering factor of hidradenitis suppurativa. Dermatology 198:261–4
Lookingbill DP (1988) Yield from a complete skin examination. Findings in
1157 new dermatology patients. J Am Acad Dermatol 18:31–7
Maradit Kremers H, Crowson CS, Gabriel SE (2004) Rochester Epidemiology
Project: a unique resource for research in the rheumatic diseases. Rheum
Dis Clin North Am 30:819–34, vii
Matusiak L, Bieniek A, Szepietowski JC (2010a) Hidradenitis suppurativa
markedly decreases quality of life and professional activity. J Am Acad
Dermatol 62:706–8, 8 e1
Matusiak L, Bieniek A, Szepietowski JC (2010b) Psychophysical aspects of
hidradenitis suppurativa. Acta Dermatol Venereol 90:264–8
Table 6. Diagnostic criteria for hidradenitis
suppurativa and Hurley staging system
Hidradenitis suppurativa diagnostic criteria1
(1) Is there more than a single inflamed lesion?
(2) Is the course chronic with new and recurrent lesions?
(3) Are the lesions bilateral?
(4) Are the lesions located primarily in the milk line?
Hurley staging
(I) Abscess formation (single or multiple) without sinus tracts and
cicatrization.
(II) One or more widely separated recurrent abscesses with tract formation
and scars.
(III) Multiple interconnected tracts and abscesses throughout an entire
area.
1Patients had to meet all four criteria for study inclusion, except in
cases of atypical locations (e.g., perianal or perineal, buttock or gluteal
cleft, neck or ear, scrotum) in which lesions are not primarily located in
the milk line.
102 Journal of Investigative Dermatology (2013), Volume 133
BG Vazquez et al.
Incidence of Hidradenitis Suppurativa
McCullagh P, Nelder JA (1983) Generalized Linear Models. Chapman and
Hall: London; New York, xiii, 261pp
Melton 3rd LJ (1996) History of the Rochester Epidemiology Project. Mayo
Clin Proc 71:266–74
Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F
et al. (2008) Prevalence and factors associated with hidradenitis
suppurativa: results from two case-control studies. J Am Acad Dermatol
59:596–601
Sartorius K, Emtestam L, Jemec GB, Lapins J (2009) Objective scoring of
hidradenitis suppurativa reflecting the role of tobacco smoking and
obesity. Br J Dermatol 161:831–9
Simonart T (2010) Hidradenitis suppurativa and smoking. J Am Acad
Dermatol 62:149–50
Thornton JP, Abcarian H (1978) Surgical treatment of perianal and perineal
hidradenitis suppurativa. Dis Colon Rectum 21:573–7
van der Zee HH, van der Woude CJ, Florencia EF, Prens
EP (2010) Hidradenitis suppurativa and inflammatory bowel
disease: are they associated? Results of a pilot study. Br J Dermatol 162:
195–7
Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J (2007) Quality of life
impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad
Dermatol 56:621–3
www.jidonline.org 103
BG Vazquez et al.
Incidence of Hidradenitis Suppurativa
